Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Stephanie Schlichtner, Inna M. Yasinska, Elena Klenova, Maryam Abooali, Gurprit S. Lall, Steffen M. Berger, Sabrina Ruggiero, Dietmar Cholewa, Milan Milošević, Bernhard F. Gibbs, Elizaveta Fasler-Kan & Vadim V. Sumbayev. (2023) L-Kynurenine participates in cancer immune evasion by downregulating hypoxic signaling in T lymphocytes. OncoImmunology 12:1.
Read now
Read now
Joshua W. Morse, Margarita Rios, John Ye, Adan Rios, Cheng Cheng Zhang, Naval G. Daver, Courtney D. DiNardo, Ningyan Zhang & Zhiqiang An. (2023) Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets. Expert Opinion on Investigational Drugs 32:2, pages 107-125.
Read now
Read now
Kateřina Kuželová, Barbora Brodská, Jana Marková, Martina Petráčková, Johannes Schetelig, Šárka Ransdorfová, Zdenka Gašová & Cyril Šálek. (2022) NPM1 and DNMT3A mutations are associated with distinct blast immunophenotype in acute myeloid leukemia. OncoImmunology 11:1.
Read now
Read now
Amer M Zeidan, Rami S Komrokji & Andrew M Brunner. (2021) TIM-3 pathway dysregulation and targeting in cancer. Expert Review of Anticancer Therapy 21:5, pages 523-534.
Read now
Read now
Dong Zhang, Feng Jiang, Rinat Zaynagetdinov, Hui Huang, Vanita D. Sood, Hong Wang, Xinyan Zhao, Molly H. Jenkins, Qingyong Ji, Youbin Wang, David P. Nannemann, Djordje Musil, John Wesolowski, Andrea Paoletti, Tin Bartholomew, Melissa G. Derner, Qi An, Christel Iffland & Joern-Peter Halle. (2020) Identification and characterization of M6903, an antagonistic anti–TIM-3 monoclonal antibody. OncoImmunology 9:1.
Read now
Read now
Zeynep Arzu Yegin, Ferda Can, Lale Aydın Kaynar, Sanem Gökçen, Rezzan Eren Sadioğlu, Zübeyde Nur Özkurt & Özlem Karacaoğlu. (2020) Pre-transplant sTIM-3 levels may have a predictive impact on transplant outcome in acute leukemia patients. Hematology 25:1, pages 125-133.
Read now
Read now
Inna M. Yasinska, Isabel Gonçalves Silva, Svetlana S. Sakhnevych, Laura Ruegg, Rohanah Hussain, Giuliano Siligardi, Walter Fiedler, Jasmin Wellbrock, Marco Bardelli, Luca Varani, Ulrike Raap, Steffen Berger, Bernhard F. Gibbs, Elizaveta Fasler-Kan & Vadim V. Sumbayev. (2018) High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression. OncoImmunology 7:6.
Read now
Read now
Articles from other publishers (41)
Hao Zhang, Li Yang, Tingting Wang & Zhen Li. (2024) NK cell-based tumor immunotherapy. Bioactive Materials 31, pages 63-86.
Crossref
Crossref
María F. Troncoso, María T. Elola, Ada G. Blidner, Luciana Sarrias, María V. Espelt & Gabriel A. Rabinovich. (2023) The universe of galectin-binding partners and their functions in health and disease. Journal of Biological Chemistry 299:12, pages 105400.
Crossref
Crossref
Maryam Bakhtiyari, Mahsa Liaghat, Fatemeh Aziziyan, Hooriyeh Shapourian, Sheida Yahyazadeh, Maedeh Alipour, Shaghayegh Shahveh, Fahimeh Maleki-Sheikhabadi, Hossein Halimi, Razieh Forghaniesfidvajani, Hamidreza Zalpoor, Mohsen Nabi-Afjadi & Majid Pornour. (2023) The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways. Cell Communication and Signaling 21:1.
Crossref
Crossref
Mao Li, Zi‐xin Wan, Yue‐yang Tang, Xin‐hua Liang & Ya‐ling Tang. (2023)
TIM
‐3/Galectin‐9 and
CD160
expression in salivary adenoid cystic carcinoma
. Oral Diseases.
Crossref
Crossref
Xingmei Mu, Chumao Chen, Loujie Dong, Zhaowei Kang, Zhixian Sun, Xijie Chen, Junke Zheng & Yaping Zhang. (2023) Immunotherapy in leukaemia. Acta Biochimica et Biophysica Sinica 55:6, pages 974-987.
Crossref
Crossref
Frankie Chi Fat Ko, Sheng Yan, Ka Wai Lee, Sze Kwan Lam & James Chung Man Ho. (2023) Chimera and Tandem-Repeat Type Galectins: The New Targets for Cancer Immunotherapy. Biomolecules 13:6, pages 902.
Crossref
Crossref
Teppei Sakoda, Yoshikane Kikushige, Toshihiro Miyamoto, Hidetoshi Irifune, Takuya Harada, Kiwamu Hatakeyama, Yuya Kunisaki, Koji Kato & Koichi Akashi. (2023) TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia. Blood Advances 7:10, pages 2053-2065.
Crossref
Crossref
Başak Aru, Cemil Pehlivanoğlu, Zeynep Dal, Nida Nur Dereli-Çalışkan, Ege Gürlü & Gülderen Yanıkkaya-Demirel. (2023) A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia. Frontiers in Immunology 14.
Crossref
Crossref
Stephanie Schlichtner, Inna M Yasinska, Gurprit S Lall, Steffen M Berger, Sabrina Ruggiero, Dietmar Cholewa, Nijas Aliu, Bernhard F Gibbs, Elizaveta Fasler-Kan & Vadim V Sumbayev. (2023) T lymphocytes induce human cancer cells derived from solid malignant tumors to secrete galectin-9 which facilitates immunosuppression in cooperation with other immune checkpoint proteins. Journal for ImmunoTherapy of Cancer 11:1, pages e005714.
Crossref
Crossref
E. V. Morozova, N. Yu. Tsvetkov, M. V. Barabanshchikova, K. S. Yurovskaya & I. S. Moiseev. (2022) New perspectives in the treatment of patients with intermediate-2 and high-risk myelodysplastic syndrome. Oncohematology 17:4, pages 106-117.
Crossref
Crossref
Li Qin, Weixiong Zheng, Shiming Jiang, Hao Tang, Meng Cai, Anke Chen & Yong Chen. (2022) Noninvasive Prediction of Immune Rejection After Liver Transplantation with T cell immunoglobulin domain, and mucin domain-3. Transplantation Proceedings 54:7, pages 1881-1886.
Crossref
Crossref
Anna Paola Carreca, Massimiliano Gaetani, Rosalia Busà, Maria Giovanna Francipane, Maria Rita Gulotta, Ugo Perricone, Gioacchin Iannolo, Giovanna Russelli, Claudia Carcione, Pier Giulio Conaldi & Ester Badami. (2022) Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection. Viruses 14:7, pages 1538.
Crossref
Crossref
Si‐Jia Zhao, Kahindo P. Muyayalo, Jing Luo, Donghui Huang, Gil Mor & Ai‐Hua Liao. (2022) Next generation of immune checkpoint molecules in maternal‐fetal immunity*. Immunological Reviews 308:1, pages 40-54.
Crossref
Crossref
Katsuhiro Yoshikawa, Mitsuaki Ishida, Hirotsugu Yanai, Koji Tsuta, Mitsugu Sekimoto & Tomoharu Sugie. (2022) Prognostic significance of the expression levels of T‑cell immunoglobulin mucin‑3 and its ligand galectin‑9 for relapse‑free survival in triple‑negative breast cancer. Oncology Letters 23:6.
Crossref
Crossref
Riyao Yang, Linlin Sun, Ching-Fei Li, Yu-Han Wang, Weiya Xia, Boning Liu, Yu-Yi Chu, Laura Bover, Long Vien & Mien-Chie Hung. (2022) Development and characterization of anti-galectin-9 antibodies that protect T cells from galectin-9-induced cell death. Journal of Biological Chemistry 298:4, pages 101821.
Crossref
Crossref
Miyoung Lee, Jamie A. G. Hamilton, Ganesh R. Talekar, Anthony J. Ross, Langston Michael, Manali Rupji, Bhakti Dwivedi, Sunil S. Raikar, Jeremy Boss, Christopher D. Scharer, Douglas K. Graham, Deborah DeRyckere, Christopher C. Porter & Curtis J. Henry. (2022) Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia. Nature Communications 13:1.
Crossref
Crossref
Avraham Unterman, Tomokazu S. Sumida, Nima Nouri, Xiting Yan, Amy Y. Zhao, Victor Gasque, Jonas C. Schupp, Hiromitsu Asashima, Yunqing Liu, Carlos CosmeJr.Jr., Wenxuan Deng, Ming Chen, Micha Sam Brickman Raredon, Kenneth B. Hoehn, Guilin Wang, Zuoheng Wang, Giuseppe DeIuliis, Neal G. Ravindra, Ningshan Li, Christopher Castaldi, Patrick Wong, John Fournier, Santos Bermejo, Lokesh Sharma, Arnau Casanovas-Massana, Chantal B. F. Vogels, Anne L. Wyllie, Nathan D. Grubaugh, Anthony Melillo, Hailong Meng, Yan Stein, Maksym Minasyan, Subhasis Mohanty, William E. Ruff, Inessa Cohen, Khadir Raddassi, Allison Nelson, Denise Shepard, Michael Rainone, Xiaohua Peng, Laura E. Niklason, Albert I. Ko, Ruth R. Montgomery, Shelli F. Farhadian, Akiko Iwasaki, Albert C. Shaw, David van Dijk, Hongyu Zhao, Steven H. Kleinstein, David A. Hafler, Naftali Kaminski & Charles S. Dela Cruz. (2022) Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19. Nature Communications 13:1.
Crossref
Crossref
Maximilian Fleischmann, Ulf Schnetzke, Andreas Hochhaus & Sebastian Scholl. (2021) Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives. Cancers 13:22, pages 5722.
Crossref
Crossref
Hooriyeh Shapoorian, Hamidreza Zalpoor & Mazdak Ganjalikhani-Hakemi. (2021) The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia. Blood Science 3:4, pages 132-135.
Crossref
Crossref
Sashi Kandel, Pratik Adhikary, Guangfu Li & Kun Cheng. (2021) The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy. Cancer Letters 510, pages 67-78.
Crossref
Crossref
Anette Teo Hansen Selnø, Stephanie Schlichtner, Inna M. Yasinska, Svetlana S. Sakhnevych, Walter Fiedler, Jasmin Wellbrock, Steffen M. Berger, Elena Klenova, Bernhard F. Gibbs, Elizaveta Fasler-Kan & Vadim V. Sumbayev. (2021) High Mobility Group Box 1 (HMGB1) Induces Toll-Like Receptor 4-Mediated Production of the Immunosuppressive Protein Galectin-9 in Human Cancer Cells. Frontiers in Immunology 12.
Crossref
Crossref
Zhiding Wang, Jinghong Chen, Mengzhen Wang, Linlin Zhang & Li Yu. (2021) One Stone, Two Birds: The Roles of Tim-3 in Acute Myeloid Leukemia. Frontiers in Immunology 12.
Crossref
Crossref
Julian Swatler, Laura Turos-Korgul, Ewa Kozlowska & Katarzyna Piwocka. (2021) Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias. Cancers 13:6, pages 1203.
Crossref
Crossref
Sophia Khaldoyanidi, Dirk Nagorsen, Anthony Stein, Gerrit Ossenkoppele & Marion Subklewe. (2021) Immune Biology of Acute Myeloid Leukemia: Implications for Immunotherapy. Journal of Clinical Oncology 39:5, pages 419-432.
Crossref
Crossref
Saeid Taghiloo & Hossein Asgarian-Omran. (2021) Immune evasion mechanisms in acute myeloid leukemia: A focus on immune checkpoint pathways. Critical Reviews in Oncology/Hematology 157, pages 103164.
Crossref
Crossref
Md Amir Hossain, Guilai Liu, Beiying Dai, Yaxuan Si, Qitao Yang, Junaid Wazir, Lutz Birnbaumer & Yong Yang. (2020)
Reinvigorating exhausted CD8
+
cytotoxic T lymphocytes in the tumor microenvironment and current strategies in cancer immunotherapy
. Medicinal Research Reviews 41:1, pages 156-201.
Crossref
Crossref
Anette Teo Hansen Selnø, Stephanie Schlichtner, Inna M. Yasinska, Svetlana S. Sakhnevych, Walter Fiedler, Jasmin Wellbrock, Elena Klenova, Ludmila Pavlova, Bernhard F. Gibbs, Martin Degen, Isabelle Schnyder, Nijas Aliu, Steffen M. Berger, Elizaveta Fasler-Kan & Vadim V. Sumbayev. (2020) Transforming growth factor beta type 1 (TGF-β) and hypoxia-inducible factor 1 (HIF-1) transcription complex as master regulators of the immunosuppressive protein galectin-9 expression in human cancer and embryonic cells. Aging 12:23, pages 23478-23496.
Crossref
Crossref
Inna M. Yasinska, N. Helge Meyer, Stephanie Schlichtner, Rohanah Hussain, Giuliano Siligardi, Maxwell Casely-Hayford, Walter Fiedler, Jasmin Wellbrock, Cloe Desmet, Luigi Calzolai, Luca Varani, Steffen M. Berger, Ulrike Raap, Bernhard F. Gibbs, Elizaveta Fasler-Kan & Vadim V. Sumbayev. (2020) Ligand-Receptor Interactions of Galectin-9 and VISTA Suppress Human T Lymphocyte Cytotoxic Activity. Frontiers in Immunology 11.
Crossref
Crossref
Mohsen Alizadeh, Ali Safarzadeh, Seyed Ali Hoseini, Reza Piryaei, Behzad Mansoori, Khalil Hajiasgharzadeh, Amir Baghbanzadeh & Behzad Baradaran. (2020) The potentials of immune checkpoints for the treatment of blood malignancies. Critical Reviews in Oncology/Hematology 153, pages 103031.
Crossref
Crossref
Inna M. Yasinska, Svetlana S. Sakhnevych, Ludmila Pavlova, Anette Teo Hansen Selnø, Ana Maria Teuscher Abeleira, Ouafa Benlaouer, Isabel Gonçalves Silva, Marianne Mosimann, Luca Varani, Marco Bardelli, Rohanah Hussain, Giuliano Siligardi, Dietmar Cholewa, Steffen M. Berger, Bernhard F. Gibbs, Yuri A. Ushkaryov, Elizaveta Fasler-Kan, Elena Klenova & Vadim V. Sumbayev. (2019) The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer. Frontiers in Immunology 10.
Crossref
Crossref
Svetlana S. Sakhnevych, Inna M. Yasinska, Elizaveta Fasler-Kan & Vadim V. Sumbayev. (2019) Mitochondrial Defunctionalization Supresses Tim-3-Galectin-9 Secretory Pathway in Human Colorectal Cancer Cells and Thus Can Possibly Affect Tumor Immune Escape. Frontiers in Pharmacology 10.
Crossref
Crossref
Yan Zheng, Wei Feng, Yu-Juan Wang, Yan Sun, Guang Shi & Qiong Yu. (2019) Galectins as potential emerging key targets in different types of leukemia. European Journal of Pharmacology 844, pages 73-78.
Crossref
Crossref
S. Haubner, F. Perna, T. Köhnke, C. Schmidt, S. Berman, C. Augsberger, F. M. Schnorfeil, C. Krupka, F. S. Lichtenegger, X. Liu, P. Kerbs, S. Schneider, K. H. Metzeler, K. Spiekermann, W. Hiddemann, P. A. Greif, T. Herold, M. Sadelain & M. Subklewe. (2018) Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML. Leukemia 33:1, pages 64-74.
Crossref
Crossref
Svetlana S. Sakhnevych, Inna M. Yasinska, Alison M. Bratt, Ouafa Benlaouer, Isabel Gonçalves Silva, Rohanah Hussain, Giuliano Siligardi, Walter Fiedler, Jasmin Wellbrock, Bernhard F. Gibbs, Yuri A. Ushkaryov & Vadim V. Sumbayev. (2018) Cortisol facilitates the immune escape of human acute myeloid leukemia cells by inducing latrophilin 1 expression. Cellular & Molecular Immunology 15:11, pages 994-997.
Crossref
Crossref
Inna M. Yasinska, Isabel Gonçalves Silva, Svetlana Sakhnevych, Bernhard F. Gibbs, Ulrike Raap, Elizaveta Fasler-Kan & Vadim V. Sumbayev. (2018) Biochemical mechanisms implemented by human acute myeloid leukemia cells to suppress host immune surveillance. Cellular & Molecular Immunology 15:11, pages 989-991.
Crossref
Crossref
Amanda Przespolewski, Andras Szeles & Eunice S Wang. (2018) Advances in immunotherapy for acute myeloid leukemia. Future Oncology 14:10, pages 963-978.
Crossref
Crossref
Elizabeth Ann L. Enninga, Susan M. Harrington, Douglas J. Creedon, Rodrigo Ruano, Svetomir N. Markovic, Haidong Dong & Roxana S. Dronca. (2018) Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancy. American Journal of Reproductive Immunology 79:2, pages e12795.
Crossref
Crossref
宵霖 李. (2018) The Expression and Clinical Significance of CD4+Tim-3+T Cell in Peripheral Blood for Acute Henoch Schonlein Purpura Patients. Advances in Clinical Medicine 08:06, pages 585-589.
Crossref
Crossref
Inna M. Yasinska, Giacomo Ceccone, Isaac Ojea-Jimenez, Jessica Ponti, Rohanah Hussain, Giuliano Siligardi, Steffen M. Berger, Elizaveta Fasler-Kan, Marco Bardelli, Luca Varani, Walter Fiedler, Jasmin Wellbrock, Ulrike Raap, Bernhard F. Gibbs, Luigi Calzolai & Vadim V. Sumbayev. (2018) Highly specific targeting of human acute myeloid leukaemia cells using pharmacologically active nanoconjugates. Nanoscale 10:13, pages 5827-5833.
Crossref
Crossref
Jenn-Haung Lai, Shue-Fen Luo, Mei-Yi Wang & Ling-Jun Ho. (2017) Translational Implication of Galectin-9 in the Pathogenesis and Treatment of Viral Infection. International Journal of Molecular Sciences 18:10, pages 2108.
Crossref
Crossref
Isabel Gonçalves Silva, Inna M. Yasinska, Svetlana S. Sakhnevych, Walter Fiedler, Jasmin Wellbrock, Marco Bardelli, Luca Varani, Rohanah Hussain, Giuliano Siligardi, Giacomo Ceccone, Steffen M. Berger, Yuri A. Ushkaryov, Bernhard F. Gibbs, Elizaveta Fasler-Kan & Vadim V. Sumbayev. (2017) The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells. EBioMedicine 22, pages 44-57.
Crossref
Crossref